We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+11.63%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$3.6B
AUM Growth
+$334M
Cap. Flow
-$6.81M
Cap. Flow %
-0.19%
Top 10 Hldgs %
25.33%
Holding
178
New
20
Increased
59
Reduced
61
Closed
10

Top Sells

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$30.4M
2
APTV icon
Aptiv
APTV
+$24.8M
3
JNJ icon
Johnson & Johnson
JNJ
+$16.1M
4
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
+$14.7M
5
BIDU icon
Baidu
BIDU
+$13.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.75%
2 Technology 15.47%
3 Financials 14.79%
4 Communication Services 14.34%
5 Healthcare 13.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APTV icon
101
Aptiv
APTV
$10.2B
$6.44M 0.18%
80,000
-330,000
-80% -$24.8M
WOOF
102
DELISTED
VCA Inc.
WOOF
$6.41M 0.18%
70,000
-106,000
-60% -$9.51M
TRUP icon
103
Trupanion
TRUP
$1.31B
$6.4M 0.18%
+450,000
New +$6.87M
TAL icon
104
TAL Education Group
TAL
$6.55B
$6.39M 0.18%
360,000
EXPE icon
105
Expedia Group
EXPE
$38.5B
$6.31M 0.18%
50,000
+10,000
+25% +$1.22M
CL icon
106
Colgate-Palmolive
CL
$74.1B
$6.22M 0.17%
85,000
-434,000
-84% -$30.4M
ASH icon
107
Ashland
ASH
$3.4B
$6.19M 0.17%
102,200
-40,880
-29% -$2.37M
PFPT
108
DELISTED
Proofpoint, Inc.
PFPT
$6.17M 0.17%
83,000
+15,800
+24% +$1.26M
GILD icon
109
Gilead Sciences
GILD
$170B
$6.1M 0.17%
89,870
-70,000
-44% -$4.92M
KYNB
110
Kyntra Bio
KYNB
$29.3M
$5.89M 0.16%
9,560
+1,600
+20% +$974K
AMTD
111
DELISTED
TD Ameritrade Holding Corp
AMTD
$5.83M 0.16%
150,000
-46,000
-23% -$1.96M
ITUB icon
112
Itaú Unibanco
ITUB
$82.1B
$5.74M 0.16%
979,502
FMX icon
113
Fomento Económico Mexicano
FMX
$40.1B
$5.47M 0.15%
61,820
ACAD icon
114
Acadia Pharmaceuticals
ACAD
$5.11B
$5.4M 0.15%
157,000
+37,000
+31% +$1.31M
NBIX icon
115
Neurocrine Biosciences
NBIX
$16.1B
$5.2M 0.14%
120,000
+20,000
+20% +$857K
OLED icon
116
Universal Display
OLED
$4.21B
$5.13M 0.14%
59,553
+28,753
+93% +$2.07M
MON
117
DELISTED
Monsanto Co
MON
$5.09M 0.14%
45,000
+10,000
+29% +$1.11M
EA
118
DELISTED
Electronic Arts
EA
$4.92M 0.14%
55,000
ALXN
119
DELISTED
Alexion Pharmaceuticals
ALXN
$4.9M 0.14%
40,400
+4,000
+11% +$516K
BETR
120
DELISTED
Amplify Snack Brands, Inc.
BETR
$4.83M 0.13%
575,000
+225,000
+64% +$2.17M
BAX icon
121
Baxter International
BAX
$14B
$4.82M 0.13%
+93,000
New +$4.57M
GGAL icon
122
Galicia Financial Group
GGAL
$7.04B
$4.71M 0.13%
124,500
BMY icon
123
Bristol-Myers Squibb
BMY
$130B
$4.65M 0.13%
85,560
-30,000
-26% -$1.65M
HASI icon
124
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.35B
$4.55M 0.13%
225,228
+127,728
+131% +$2.45M
IMAX icon
125
IMAX
IMAX
$2.76B
$4.42M 0.12%
+130,000
New +$4.24M

Similar funds

Handelsbanken Fonder's Q1 2017 Portfolio in Review

As of Q1 2017, Handelsbanken Fonder held 178 positions worth $3.6B, up 10% from $3.27B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Handelsbanken Fonder's Q1 2017 filing shows 20 new, 59 increased, 61 reduced and 10 closed positions. Its largest new stake was Hormel Foods: 757,500 shares worth $26.2M. The largest sale was Colgate-Palmolive, an estimated $30.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • Handelsbanken Fonder's largest Q1 2017 buy was Hormel Foods: 757,500 shares worth $26.2M.
  • Handelsbanken Fonder added most to Alibaba in Q1 2017, an estimated $37.7M increase.
  • Handelsbanken Fonder's biggest Q1 2017 reduction was Colgate-Palmolive, cutting an estimated $30.4M.
  • Handelsbanken Fonder fully exited Huron Consulting in Q1 2017, selling an estimated $8.59M.
  • Handelsbanken Fonder's ten largest holdings make up 25% of its $3.6B portfolio in Q1 2017.
  • Handelsbanken Fonder opened 20 new positions and closed 10 in Q1 2017.
  • Handelsbanken Fonder's portfolio value rose 10% quarter-over-quarter to $3.6B.

Based on Handelsbanken Fonder's 13F filing for Q1 2017, filed 4 May 2017.